pyridostigmine bromide has been researched along with levodopa in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 8 (61.54) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Gilbert, JC | 1 |
| Arvat, E; Bellone, J; Boffano, GM; Cappa, M; De Sanctis, C; Ghigo, E; Imperiale, E; Loche, S; Mazza, E; Valetto, MR | 1 |
| Camanni, F; Cella, SG; Ghigo, E; Locatelli, V; Loche, S; Müller, EE; Pintor, C | 1 |
| Arvat, E; Bellone, J; Camanni, F; Ghigo, E; Imperiale, E; Mazza, E; Procopio, M | 1 |
| Huh, KB; Kim, KR; Lee, DJ; Lee, EJ; Lee, HC; Lee, JH; Lee, KM; Lim, SK | 1 |
| Huh, KB; Lee, BS; Lee, EJ; Lee, HC; Park, KH; Song, CH | 1 |
| Barkan, AL; DeMott-Friberg, R; Jaffe, CA | 1 |
| Aimaretti, G; Bartolotta, E; Bellone, J; Bellone, S; Camanni, F; Cappa, M; Dammacco, F; Ghigo, E; Loche, S | 1 |
| Hanew, K; Tanaka, A; Utsumi, A | 1 |
| Giambi, C; Giuliano, S; Pallotti, S | 1 |
2 review(s) available for pyridostigmine bromide and levodopa
| Article | Year |
|---|---|
Involvement of brain catecholamines and acetylcholine in growth hormone deficiency states. Pathophysiological, diagnostic and therapeutic implications.
Topics: Acetylcholine; Brain Chemistry; Catecholamines; Growth Disorders; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Levodopa; Parasympatholytics; Pyridostigmine Bromide | 1991 |
Neuroactive drugs in growth disorders.
Topics: Bromocriptine; Central Nervous System; Child; Clonidine; False Negative Reactions; Growth Disorders; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Levodopa; Pyridostigmine Bromide | 1990 |
2 trial(s) available for pyridostigmine bromide and levodopa
| Article | Year |
|---|---|
Reduced growth hormone response to L-dopa and pyridostigmine in obesity.
Topics: Adult; Body Mass Index; Cross-Over Studies; Fatty Acids, Nonesterified; Growth Hormone; Humans; Insulin; Levodopa; Male; Obesity; Pituitary Gland; Pyridostigmine Bromide | 1994 |
Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli.
Topics: Adrenergic alpha-Agonists; Arginine; Cholinesterase Inhibitors; Clonidine; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Hormone Antagonists; Humans; Hypoglycemia; Levodopa; Male; Pyridostigmine Bromide; Secretory Rate; Somatostatin | 1996 |
9 other study(ies) available for pyridostigmine bromide and levodopa
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Diseases of the central nervous system. Pharmacological basis of treatment.
Topics: Amantadine; Analgesics, Opioid; Anticonvulsants; Blood-Brain Barrier; Central Nervous System Diseases; Cholinesterase Inhibitors; Edrophonium; Epilepsy; Headache; Humans; Levodopa; Methysergide; Migraine Disorders; Myasthenia Gravis; Parkinson Disease; Pyridostigmine Bromide; Serotonin Antagonists | 1975 |
Pyridostigmine potentiates L-dopa- but not arginine- and galanin-induced growth hormone secretion in children.
Topics: Adolescent; Arginine; Child; Drug Synergism; Drug Therapy, Combination; Female; Galanin; Growth Disorders; Growth Hormone; Humans; Levodopa; Male; Neuropeptides; Peptides; Pyridostigmine Bromide | 1990 |
Growth hormone response to L-dopa and pyridostigmine in women with polycystic ovarian syndrome.
Topics: Adolescent; Adult; Female; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Insulin-Like Growth Factor I; Levodopa; Polycystic Ovary Syndrome; Premedication; Pyridostigmine Bromide | 1993 |
Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children.
Topics: Adolescent; Arginine; Child; Child, Preschool; Clonidine; Exercise; Female; Glucagon; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypoglycemia; Insulin; Insulin-Like Growth Factor I; Levodopa; Male; Pyridostigmine Bromide; Reproducibility of Results | 1996 |
Plasma GH responses to GHRH, arginine, L-dopa, pyridostigmine, sequential administrations of GHRH and combined administration of PD and GHRH in Turner's syndrome.
Topics: Adolescent; Adult; Arginine; Body Height; Child; Cholinesterase Inhibitors; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Levodopa; Pyridostigmine Bromide; Thyrotropin; Thyrotropin-Releasing Hormone; Turner Syndrome | 1998 |
[Growth disorders in Down's syndrome: growth hormone treatment].
Topics: Adult; Blood Glucose; Body Height; Down Syndrome; Drug Evaluation; Female; Follow-Up Studies; Glycated Hemoglobin; Growth Disorders; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Levodopa; Male; Pyridostigmine Bromide; Thyroid Hormones; Treatment Outcome | 2002 |